FOUNDATION
MISSION
The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.
The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.
NEED
Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.
SOLUTION
Cardiovascular Innovations annual meeting provides an educational forum for health care practitioners to learn the newest innovation in the delivery of cardiovascular care. Through educational tracks and lectures designed to identify the benefits of endovascular, surgical, and medical therapy, attendees are able select appropriate patients for vascular revascularization and utilize more advanced techniques to treat complex disease such as carotid stenosis, acute DVT, pulmonary embolism, PAD, and CLI.
BOARD OF DIRECTORS
Subhash Banerjee,
MD, FACC, FSCAI
Professor of Medicine – University of Texas Southwestern Medical Center
Chief – Division of Cardiology
Director – Cardiac Catheterization Laboratory VA North Texas Health Care System
Emmanouil S. Brilakis,
MD, PhD, FACC, FAHA,
FSCAI, FESC
Director – Center for Complex Coronary Interventions Minneapolis Heart Institute at Abbott Northwestern Hospital
Mehdi H. Shishehbor,
DO, MPH, PhD, FACC,
FAHA, FSCAI
Professor of Medicine – CWRU Co-Chair, Harrington Heart & Vascular Institute
Director – Cardiovascular Interventional Center
Co-Director -Vascular Center University Hospitals of Cleveland
Paul Sorajja, MD, FACC,
FAHA, FSCAI
Director – Center for Valve and Structural Heart Disease Minneapolis Heart Institute at Abbott Northwestern Hospital
Director – Valve Science Center Minneapolis Heart Institute Foundation
EDUCATION
COVID-19 Cath Lab Implications: Frontline View from Italy
Presenter: Professor Giuseppe Tarantini, President, Italian Society of Interventional Cardiology (GISE)
Moderated discussion and audience Q&A: Subhash Banerjee, MD; Emmanouil Brilakis, MD, PhD; Mehdi Shishehbor, DO, MPH, PhD ; and Paul Sorajja, MD
Provided by Cardiovascular Innovations Foundation
ECMO Indication, Implications, and Algorithm at the Time of COVID-19
Presenters:
- Melissa Brunsvold, MD, University of Minnesota Medical School
- Amy Hackman, MD, University of Texas Southwestern Medical Center
- Marc Pelletier, MD, MSC, University Hospitals, Case Western Reserve University
- Kasia Hryniewicz, MD, Minneapolis Heart Institute® at Abbott Northwestern Hospital
Moderated discussion and audience Q&A: Subhash Banerjee, MD; Emmanouil Brilakis, MD, PhD; Mehdi Shishehbor, DO, MPH, PhD; and Paul Sorajja, MD
Provided by Cardiovascular Innovations Foundation
Primary PCI or Lytics for STEMI During COVID-19 Pandemic
Presenters:
-
Mauro Carlino, MD, IRCCS San Raffaele Scientific Institute, Milan, Italy
-
Srihari S. Naidu, MD, FACC, FAHA, FSCAI, Westchester Medical Center
-
Sandeep Nathan, MD, MSc, FACC, FSCAI, The University of Chicago Medicine
-
Rajan Patel, MD, FACC, FAHA, FSCAI, Ochsner Medical Center
Provided by Cardiovascular Innovations Foundation
TECHNICAL CASES FROM THE OPERATORS ENCLAVE
Dr. Emmanouil Brilakis and Dr. Iosif Xenogiannis review a case of a 41-year-old male with inferior STEMI
Dr. Emmanouil Brilakis and Dr. Michael Megaly review a case of an 81-year-old female with an angina
Dr. Emmanouil Brilakis, Dr. Evi Vemmou, and Dr. Iosif Xenogiannis review a case featuring a 69-year-old male CCS class III angina refractory to medical therapy
Vascular Access Management During Complex PCI
Dr. Subhash Banerjee highlights how to manage patients with advanced coronary and peripheral artery disease.
Presentations recorded at Cardiovascular Innovations 2019. CVI 2019 was hosted by Cardiovascular Innovations Foundation at the Hyatt Regency, Denver, Colorado on July 17-20, 2019.
CARDIOVASCULAR INNOVATIONS FOUNDATION
44 Cook Street Suite #100
Denver, CO 80206